Description

2-Cyano-N-[3-(Morpholin-4-Ylcarbonyl)-5,6,7,8-Tetrahydro-4H-Cyclohepta[B]Thien-2-Yl]Acetamide is a sophisticated heterocyclic organic compound featuring a cyanoacetamide moiety linked to a complex cycloheptathiophene scaffold, making it a valuable advanced intermediate in pharmaceutical research and development. Its intricate molecular architecture is designed for high selectivity and potency, serving as a critical building block for creating novel therapeutic agents. This compound is primarily sought after by R&D chemists and process development scientists in the pharmaceutical, biotechnology, and fine chemical industries engaged in the synthesis of new chemical entities.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of novel drug candidates targeting various disease pathways.
• Kinase Inhibitor Research: Serves as a core scaffold or intermediate in the development of protein kinase inhibitors for oncology and inflammatory diseases.
• Medicinal Chemistry: Used in structure-activity relationship (SAR) studies to optimize the potency and pharmacokinetic properties of lead compounds.
• Chemical Biology Probes: Employed in the design and synthesis of molecular probes for studying enzyme function and cellular signaling pathways.
• Custom Synthesis & Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects under cGMP or research-grade conditions.
• Academic Research: Utilized in university and institutional labs for fundamental research in organic synthesis and drug discovery methodologies.

Basic Information

Item	Detail
Product Name	2-Cyano-N-[3-(Morpholin-4-Ylcarbonyl)-5,6,7,8-Tetrahydro-4H-Cyclohepta[B]Thien-2-Yl]Acetamide
CAS No.	588715-49-5
Molecular Formula	C₁₉H₂₃N₃O₃S
Molecular Weight	373.47 g/mol
Synonyms	2-Cyano-N-(3-(morpholine-4-carbonyl)-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophen-2-yl)acetamide; 588715-49-5; 2-Cyanoacetamide derivative of tetrahydrocycloheptathiophene; N-(3-(Morpholin-4-ylcarbonyl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-2-cyanoacetamide; Cyclohepta[b]thiophene-2-acetamide, N-[3-(4-morpholinylcarbonyl)-5,6,7,8-tetrahydro-4H]-, 2-cyano-; Acetamide, 2-cyano-N-[3-[(4-morpholinyl)carbonyl]-5,6,7,8-tetrahydro-4H-cyclohepta[b]thien-2-yl]-
EINECS	Contact for details

Quality Control

Our 2-Cyano-N-[3-(Morpholin-4-Ylcarbonyl)-5,6,7,8-Tetrahydro-4H-Cyclohepta[B]Thien-2-Yl]Acetamide is produced under strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation (NMR, IR, MS), to ensure it meets exacting R&D and process chemistry standards. A detailed Certificate of Analysis (COA) documenting purity, related substances, and residual solvents is provided with each shipment. We support development from non-GMP research to cGMP-grade material for advanced clinical trials.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The compound may be hygroscopic; therefore, containers should be kept tightly sealed in a dry environment to prevent moisture uptake. For long-term storage, consider inert atmosphere packaging.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Water Content (KF)	≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.